-- 
Allied Irish, Glaxo, Glencore, Shire: U.K., Irish Equity Preview

-- B y   B l a n c h e   G a t t   a n d   S a r a h   J o n e s
-- 
2011-06-24T06:44:58Z

-- http://www.bloomberg.com/news/2011-06-23/allied-irish-banks-berkeley-gsk-u-k-irish-equity-preview.html
The following is a list of companies
that may have unusual share-price changes in U.K. and Irish
markets. Stock symbols are in parentheses and prices are from
the last market close.  The FTSE 100 Index retreated 98.61 points, or 1.7 percent,
to 5,674.38 yesterday. The FTSE All-Share Index fell 1.7
percent, while Ireland’s ISEQ Index declined 1.2 percent.  Allied Irish Banks Plc (ALBK)  : The Dublin-based bank
said the state’s stake is likely to rise “substantially
beyond” its current 93 percent level as part of the bank’s
capital increase. The stock dived 5.5 percent to 15.6 euro
cents.  Bank of Ireland Plc (BKIR LN): Ireland’s largest bank may
raise a total of 2.5 billion euros ($3.6 billion) from its offer
to swap subordinated debt for equity or cash, according to Glas
Securities, the Dublin-based fixed-income firm. The shares
plunged 5.4 percent to 12.2 euro cents.  Berkeley Group Holdings Plc (BKG)  : The U.K.’s largest
homebuilder by market value said annual profit rose 19 percent
as the company sold more homes at higher prices. The stock
dropped 3 percent to 1,131 pence.  GlaxoSmithKline Plc (GSK)  : The attorney generals of 37
U.S. states and the  District of Columbia  reached a $40.8 million
settlement with Glaxo and SB Pharmco Puerto Rico Inc. to resolve
allegations they breached drug manufacturing standards. The
shares fell 0.7 percent to 1,272.5 pence.  Glencore International Plc (GLEN LN): JPMorgan Chase & Co.
rated the world’s largest commodity trader “neutral” in new
coverage and set a price estimate for the shares at 550 pence.
The stock dropped 4.8 percent to 466.65 pence.  Shire Plc (SHP)  : The drugmaker won a U.S. panel’s
backing to sell a new treatment for a generic swelling disease
that would compete with CSL Ltd.’s Berinert and Dyax Inc.
Outside advisers to the  Food and Drug Administration  voted 12-1
in favor of approval of Shire’s Firazyr for treating acute
attacks of hereditary angioedema. The FDA isn’t required to
follow their recommendations. The shares rose 0.4 percent to
1,854 pence.  Unilever (ULVR LN): The world’s second-largest consumer-
goods company appointed Harish Manwani, its president for Asia
and  Africa , as chief operating officer to spur growth in
emerging markets. The stock dropped 1.7 percent to 1,941 pence.  Vodafone Group Plc (VOD)  : Exane BNP Paribas reiterated
its “outperform” recommendation for the world’s largest
mobile-phone operator, saying the stock’s selloff offers a
“good entry point” for investors. The shares slid 0.9 percent
to 163 pence.  To contact the reporters on this story:
Blanche Gatt in London at 
 bgatt@bloomberg.net ;
Sarah Jones in London at 
 sjones35@bloomberg.net   To contact the editor responsible for this story:
Colin Keatinge at 
 ckeatinge@bloomberg.net  